|
Dr. Johnson holds the Chair of Oncology and Translational Research at the Cancer Research UK Institute for Cancer Studies, University of Birmingham. He is also Director of the Clinical Trials Unit within the Division of Cancer Studies, one of the largest of its type in the United Kingdom. Previously he was a Professor of Clinical Oncology and Head of Department at the Chinese University of Hong Kong and Director of the Sir Y.K.Pao Centre for Cancer. Dr. Johnson also previously held posts as Senior House Officer at four major London Postgraduate Centres, including the Royal Marsden Hospital, before moving to the Liver Unit at King's College Hospital, London. Here he gained initial training in hepatology, and an introduction to clinical and laboratory research in the field of biliary and GI cancer. After a two year appointment at Manchester Royal Infirmary as Senior Registrar in General Medicine and Gastroenterology he returned to the Liver Unit at King's College Hospital, London (now The Institute of Liver Studies), as Senior Lecturer and Assistant Director, in charge of the newly built extension to the Unit, the Sheikh Zaid Centre. Dr. Johnson qualified at the University of Manchester. His main clinical interest is in hepatobiliary cancer and biomarker discovery in the setting of clinical trials. He has published over 400 papers including more than 260 original papers, 43 textbook chapters and 45 review articles. | 